Key result
Surgical myocardial excision and cryocoagulation for arrhythmogenic right ventricular dysplasia resulted in 0% surgical mortality and no long-term VT recurrence in patients without LV involvement.
Why the study?
Does surgical myocardial excision and cryocoagulation prevent VT recurrence and mortality in patients with arrhythmogenic right ventricular dysplasia?
Population
8 male patients with ventricular tachycardia associated with arrhythmogenic right ventricular dysplasia…
Design
Case_series
Follow-up
long-term
Authors
Loading...
May support surgical excision plus cryocoagulation in ARVD without LV involvement; leaves open prospective validation.
Observational (n=8)
Does surgical myocardial excision and cryocoagulation prevent VT recurrence and mortality in patients with arrhythmogenic right ventricular dysplasia?
Surgical resection and cryoablation of VT foci in the right ventricle offers curative treatment for ARVD patients without left ventricular involvement.
Misaki et al. (1994) conducted an observational in Ventricular tachycardia associated with arrhythmogenic right ventricular dysplasia (n=8). Surgical treatment (myocardial excision and cryocoagulation) was evaluated on Surgical deaths or postoperative fatal complications. Surgical myocardial excision and cryocoagulation for arrhythmogenic right ventricular dysplasia resulted in 0% surgical mortality and no long-term VT recurrence in patients without LV involvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: